From: SHOX2 DNA Methylation is a Biomarker for the diagnosis of lung cancer based on bronchial aspirates
Histology | ||||||
---|---|---|---|---|---|---|
Tumor Stage | Adeno-carcinoma | Squamous Cell Carcinoma | NSCLC NOS | SCLC | Other/Unknown | All |
Stage I | 10/32 (31%) | 19/24 (79%) | 3/3 (100%) | -/- | -/- | 32/59 (54%) |
Stage II | 7/17 (41%) | 20/21 (95%) | 2/3 (67%) | 2/2 (100%) | -/- | 31/43 (72%) |
Stage III | 20/34 (59%) | 36/45 (80%) | 16/22 (73%) | 6/6 (100%) | 1/1 (100%) | 79/108 (73%) |
Stage IV | 12/23 (52%) | 6/9 (67%) | 4/8 (50%) | 20/21 (95%) | 0/1 (0%) | 42/62 (68%) |
Stage unknown | 2/3 (67%) | 3/4 (75%) | 1/1 (100%) | -/- | 0/1 (0%) | 6/9 (67%) |
All | 51/109 (47%) | 84/103 (82%) | 26/37 (70%) | 28/29 (97%) | 1/3 (33%) | 190/281 (68%) |